« strona główna

Dania - archiwum wiadomości [149]

Dania - flaga narodowa

    159 | 158 | 157 | 156 | 155 | 154 | 153 | 152 | 151 | 150 | 149 | 148 | 147 | 146 | 145 | 144 | 143 | 142 | 141 | 140

  • Climate Change: Reaching Climate Deal Will Boost Private Sector (2009-04-24 14:15:11)
    Global business leaders at a United Nations-backed gathering today stressed the importance of reaching an ambitious climate change deal later this year, noting that such a pact will spur the growth of a green economy.
  • First Evidence For DNA-based Vaccination Against Chronic Hepatitis C (2009-04-24 18:42:03)
    In the first clinical trial of a therapeutic vaccination using naked DNA delivered by in vivo electroporation , antiviral effects were shown in patients with hepatitis C . Researchers hope that this will encourage further clinical development.
  • GlobeImmune, Inc.s Hepatitis C Therapeutic Vaccine, GI-5005,... (2009-04-24 23:01:50)
    The study data will be presented in a poster presentation tomorrow by Eric Lawitz, M.D., of Alamo Medical Research Center, San Antonio, Tex.
  • ANA598 Demonstrates Potent Antiviral Activity At All Dose Levels In... (2009-04-25 07:09:43)
    Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 24 Apr 2009 - 4:00 PDT Anadys Pharmaceuticals, Inc.
  • Drilling drives a wedge at climate change summit (2009-04-25 11:48:56)
    That was the issue that drove a wedge Friday between young people and many of the older delegates at the United Nations-affiliated Indigenous Peoples Global Summit on Climate Change.
  • Medivir: New Phase IIa Data on TMC435 in Patients with Hepatitis C... (2009-04-26 07:13:52)
    Apr 24, 2009 - Regulatory News: Data were presented from the phase IIa trial for TMC435 at the ongoing 44th Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark, April 22-26. TMC435 is an investigational protease inhibitor, being developed by Tibotec in collaboration with Medivir , for the treatment of ...
  • OctoPlus Licensee Biolex Presents Locteron Phase IIa Results At EASL Conference (2009-04-26 15:20:53)
    Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials Article Date: 26 Apr 2009 OctoPlus N.V. announces that its licensee Biolex Therapeutics will present the results from its United States Phase IIa clinical study with Locteron today at the 44th Annual Meeting of the European Association for the Study of the ...
  • Metal Detectorist Finds Silver Hoard in Denmark (2009-04-27 03:50:38)
    Submitted by Ursula on Sun, 2009/04/26 - 18:22. A hobbyist with a metal detector discovered a thousand-year-old hoard of Viking-era silver on the Danish island of Funen.
  • Alcohol-Related Diseases Account For 1.25 Percent Of Health Expenditure In Portugal (2009-04-27 11:51:12)
    Main Category: Alcohol / Addiction / Illegal Drugs Also Included In: Liver Disease / Hepatitis Article Date: 24 Apr 2009 Liver disease is the most prevalent cause of alcohol-related deaths, followed by car accidents and cancer, according to new research conducted in Portugal and presented at EASL 2009, the Annual Meeting of the European Association ...
  • Clinton tells nations US acting on climate change (2009-04-27 19:47:52)
    Secretary of State Hillary Rodham Clinton told representatives from 16 major world economies Monday that the United States is moving quickly to address global warming.
  • 159 | 158 | 157 | 156 | 155 | 154 | 153 | 152 | 151 | 150 | 149 | 148 | 147 | 146 | 145 | 144 | 143 | 142 | 141 | 140


© 2006-2022 wieszwszystko.com - serwisy informacyjne